Pfizer and it's German partner BioNTech will now seek U.S. authorization to distribute their COVID-19 vaccine to the 5-11 age group following a successful Phase 2/3 clinical trial.
UNITED STATES - Pfizer says it's COVID-19 vaccine works for kids between the ages of 5 and 11.
It tested a much lower dose of the vaccine, a third of what's in the average shot now, for the elementary school-aged kids. A report in the Associated Press states the fully vaccinated kids developed coronavirus-fighting antibody levels comparable to those in teenagers and young adults.
Pfizer and its German partner BioNTech will now seek authorization for the 5 to 11 age group in the United States.
The Pfizer-BioNTech vaccine is already being distributed to anyone over the age of 12 in the United States, Canada and in other countries around the world.

Oxford OPP Briefs - Nov. 3rd, 2025
Interview with the Mayor - November 3rd, 2025
PJHL Recap - Oct 31st to Nov 2nd
Nominations Open for Runway of Stars
Ultimate Burger Battle Begins!
Dodgers Beat Blue Jays in World Series
Impaired Driver Caught in Tillsonburg
Norfolk OPP Investigating Break-and-Enter
PJHL Preview - Oct. 31st to Nov. 2nd
BBBS Volunteers Honoured in London
Poppy Campaign Begins Today
Daylight Saving Time Ends on Sunday
Local Police Offer Halloween Safety Tips
UPDATE: Missing Teen Located
Men's Health Talk Coming to Woodstock
WPS Search for Robbery Suspect
Navy Vets Change Coaching Staff
Great Pumpkin Rescue Returns to Oxford
UPDATE: Missing Boy Found Safe
WFD Investigating Forest Fire
Comments
Add a comment